Gravidity, or the number of pregnancies a woman has had, is linked to a number of biochemical alterations, including changes in cardiovascular parameters. These modifications may increase the likelihood of cardiovascular disease in this population. The aim of this research was to evaluate the effect gravidity has on some cardiovascular markers among normotensive pregnant women. A cross-sectional study of 100 women of reproductive age was carried out at Rivers State University and Rivers State University Teaching Hospital, the subjects were chosen at random for the study. Blood samples were taken and tested for total cholesterol, triglycerides, high density lipoprotein, uric acid, and Apolipoprotein A1 and B. Apolipoprotein A1 and B were all measured in blood samples for biochemical analysis. The levels of low density lipoprotein and very low density lipoprotein were determined. Graph Pad Prism Version 8.0.2.263 was used to analyze the data from the study. Result gotten from the study showed that Gravidity had no significant effect on biochemical parameters (TC, TG, UA, LDL, Apo A1, Apo B, CRP, and VLDL) in pregnant women (P>0.05), but there was a significant increase (P<0.05) in HDL levels among the group; 0.87 ± 0.21 (1-2), 0.93 ± 0.21 (3-4), 0.86 ± 0.12(5-6) and 1.30 ± 0.00 for (7-8). The effect of gravidity (1-2, 3-4, 5-6, 7-8) on HDL was shown to be significant for ANOVA and Turkey post hoc multiple comparison test; (1-2 vs 7-8) (P= 0.0204) and (5-6 vs 7-8) (P= 0.0250).. This study demonstrated that gravidity had little or no effect on the biochemical parameters but increases the HDL cholesterol level in normotensive pregnant women.   

Background: In developed countries, heart disease and stroke are the major causes of death. One of the main risk factors of cardiovascular disease is dyslipidemia, and this could be due to increased lipoproteins and/or decreased plasma clearance. Pregnancy is marked with changes in metabolism in preparation for the developing fetus and lactation after delivery. Pregnancy causes long-term metabolic and vascular changes, which may raise the general risk of heart disease. Aim: The goal of this study was to see how cardiovascular indicators changed during pregnancy in hypertensive pregnant women at Rivers State University Teaching Hospital. Methodology: The study included 150 people who were divided into three groups: Non-pregnant hypertensive women (50), pregnant hypertensive women (50), and pregnant hypertensive women (50). (50 hypertensive pregnant women). After giving their consent, subjects were chosen using a simple random procedure. Total cholesterol (TC), high density lipoprotein (HDL), triglyceride (TG), low lipoprotein density (LDL), very low density lipoprotein (VLDL), uric acid (UA), C-Reactive protein (CRP), apoprotein A1 (APoA1), and apoprotein B (APoB1) were all measured in the lab using the venipuncture technique under fasting conditions (APoB). Results: The findings revealed that there was a significant difference in each of the examined parameters (P<0.05) between hypertensive non-pregnant, 2nd trimester, and 3rd trimester pregnant women, with the exception of HDL, TG, and VLDL (P>0.05). Conclusion: This study has shown that hypertensive pregnant women are potential future candidates of cardiovascular disease.

Background: Pregnancy is a period in which a woman carries one or more foetus in her uterus. It is typically divided into three trimesters based on gestational age which is measured in weeks and months. Gravidity is referred to the number of times a woman has been pregnant. Pregnancy comes with several changes in metabolism, resulting to changes biochemical markers in pregnant women, some of which to certain extent may pose health risks in those with existing health conditions such as high blood pressure. The study of these changes becomes necessary to determine and arrest the risks should they exist during pregnancy. Aim: The study was aimed at evaluating the effects of gravidity on biochemical markers in normotensive and hypertensive 3rd trimester pregnant women. Materials and Methods: At Rivers State University Teaching Hospital, a cross-sectional study was conducted on 100 women. The consenting patients who met the inclusion criteria were randomly assigned to one of two groups: normotensive (50 normotensive pregnant women at their third trimester) or hypertensive (50 hypertensive pregnant women at their third trimester) (HPW2T). The subjects in each group were subsequently split into three categories depending on gravidity: primigravida (one pregnancy), multigravida (two or more), and grand multigravida (five or more). For the assessment of TC, TG, HDL, and LDL, fasting blood samples were taken using the venepuncture technique. AIP, CR-I, CR-II, AC, and APoB/APoA1) biochemical indices were computed quantitatively. At a p<0.05, the data were examined using ANOVA and the Tukey comparison test. Result: There was no significant difference in the mean levels of the biochemical parameters among the gravidity groups in the normotensive group except for LDL and APoB levels that was significantly higher, p<0.05. The hypertensive group had no significant difference in the mean levels of all studied parameters among the gravidity group, p>0.05.. Conclusion: In this study conducted at Rivers State University Teaching Hospital, gravidity had no impact on most biochemical markers in normotensive and hypertensive pregnant women at their third trimester.